Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
Quick Stats
Jan 30, 202659.5
AI Score
HOLD4.68
Volume Ratio
Next Earnings
16
+ve Days (30d)
13
-ve Days (30d)
THAR Stock Summary
Last updated Jan 30, 2026
THAR is currently trading at $4.89, positioned above its 200-day moving average of $2.43, indicating a long-term uptrend. The stock has a 52-week range of $0.952 to $9.08.
Technical Analysis: The 50-day moving average stands at $2.81, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 81.319, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.302, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates THAR at 59.5/100 with a HOLD recommendation.
THAR (Tharimmune, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 81.319 |
| CMF (20) | 0.302 |
| ROC (10) | 65.203 |
| ADX (14) | 46.535 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.372 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -4.803 |
| MFI (14) | 91.004 |
THAR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
THAR Price vs Max Options Open Interest
THAR Max Change In Options Open Interest
THAR Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
THAR Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
THAR Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
THAR Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Tharimmune, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
THAR Moving Averages Analysis
Tharimmune, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Tharimmune, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
THAR (Tharimmune, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.48 |
| 20 | 3.25 |
| 30 | 3.03 |
| 50 | 2.81 |
| 100 | 2.95 |
| 200 | 2.43 |
THAR Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 160.1 million |
| Earnings/Share ($) | -3.68 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -7.06 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | 5 |
| Most Recent Quarter |
News Summary: $THAR announced a new offering of 205,777 common shares at $4.50/share, along with pre-funded warrants. The offering price is a 42% discount to the current market price of $7.71/share. This has led to concerns about dilution and potential selling pressure, with a recommendation for investors to wait for the stock to settle near the $4.50-$5.00 range before considering entry. Some investors are bullish on $THAR, while others are considering shorting the stock.
Updated 2025-08-27 15:00:02